Effect of intravenous albumin on endotoxin removal, cytokines, and nitric oxide production in patients with cirrhosis and spontaneous bacterial peritonitis.
about
Albumin treatment regimen for type 1 hepatorenal syndrome: a dose-response meta-analysis.Association between lymphocyte-to-monocyte ratio (LMR) and the mortality of HBV-related liver cirrhosis: a retrospective cohort studyIntravenous albumin for the prevention of contrast-induced nephropathy in patients with liver cirrhosis and chronic kidney disease undergoing contrast-enhanced CT.Clinical use of albumin.Albumin: pathophysiologic basis of its role in the treatment of cirrhosis and its complications.Albumin in chronic liver disease: structure, functions and therapeutic implications.Anti-inflammatory effects of platelet biomaterials in a macrophage cellular model.Hyperoncotic colloids and acute kidney injury: a meta-analysis of randomized trialsRole of albumin in cirrhosis: from a hospitalist's perspective.Albumin Counteracts Immune-suppressive Effects of Lipid Mediators in Patients With Advanced Liver Disease.Concerning Chapter 5 - Human Albumin; in Cross-Sectional Guidelines for Therapy with Blood Components and Plasma Derivatives, 4th ed. Transfus Med Hemother 2009;36(6):399-407.Heparin-immobilized microspheres for the capture of cytokines.Albumin infusion improves renal blood flow autoregulation in patients with acute decompensation of cirrhosis and acute kidney injury.The Roche Immunoturbidimetric Albumin Method on Cobas c 501 Gives Higher Values Than the Abbott and Roche BCP Methods When Analyzing Patient Plasma Samples.Efficacy of vasopressin V2 receptor antagonist tolvaptan in treatment of hepatic edema.The 22/11 risk prediction model: a validated model for predicting 30-day mortality in patients with cirrhosis and spontaneous bacterial peritonitis.Spontaneous bacterial and fungal peritonitis in patients with liver cirrhosis: A literature review.Renal Failure in Patients with Liver Cirrhosis: Novel Classifications, Biomarkers, Treatment
P2860
Q35852815-CFA3711C-E697-4FCC-B0CA-869CFA82A162Q35998990-F3CDCA93-DADA-484D-90B7-E20588286584Q36468598-E7A55A4C-13BA-4515-B8BC-34672C5300D1Q37370312-C8B3DA64-05C2-4F51-A319-545BC425536CQ38083035-E2E386ED-F43C-4136-B142-71A7A5D4BEFCQ38595462-D25F5668-0591-4D0B-AB8B-45D81962FB55Q38883852-0CE724FB-3D4C-4596-8EF5-B39C2E746B04Q39198777-1CB7C1B7-C7F6-4754-B3FA-961C16F6125AQ39387113-CD7D3D76-4905-41CE-BC84-1E50FF1C25B7Q40072046-846BB6B2-F2D6-421D-86DB-235B43017910Q41829455-E524F413-B803-4D98-B731-EC992A7CFA23Q42230430-3ADACA5C-A0C2-4B92-BBDE-8D2D53F7F82EQ44470119-5A378FC5-8F4D-4C26-B91F-40FFB72EA2D5Q48808543-791C7985-5FEB-4780-9B19-1961170EEBF6Q51623426-9A8FAB35-1492-46A5-922C-68F87E3A71F2Q53097446-E7BA2106-95F7-4C1A-84D4-61783D119ED8Q53703031-05D31697-DFC5-4F83-8886-2B693A1B35C1Q57824694-5D5ED0C3-63B1-4E2B-BEBF-D24A983053DD
P2860
Effect of intravenous albumin on endotoxin removal, cytokines, and nitric oxide production in patients with cirrhosis and spontaneous bacterial peritonitis.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Effect of intravenous albumin ...... taneous bacterial peritonitis.
@en
Effect of intravenous albumin ...... taneous bacterial peritonitis.
@nl
type
label
Effect of intravenous albumin ...... taneous bacterial peritonitis.
@en
Effect of intravenous albumin ...... taneous bacterial peritonitis.
@nl
prefLabel
Effect of intravenous albumin ...... taneous bacterial peritonitis.
@en
Effect of intravenous albumin ...... taneous bacterial peritonitis.
@nl
P2093
P2860
P1476
Effect of intravenous albumin ...... taneous bacterial peritonitis.
@en
P2093
Angela Chen
Chiun-Ku Lin
Hsien-Chung Yu
Lung-Chih Cheng
Ping-I Hsu
Tai-An Chen
Wei-Lun Tsai
Yu-Chen Tsao
P2860
P304
P356
10.1080/00365520902719273
P577
2009-01-01T00:00:00Z